Literature DB >> 15474332

Epidermal growth factor receptor in tumor angiogenesis.

Lee M Ellis1.   

Abstract

This article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15474332     DOI： 10.1016/j.hoc.2004.06.002

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  56 in total

Review 1.  Targeting angiogenesis in gynecologic cancers.

Authors:  Behrouz Zand; Robert L Coleman; Anil K Sood
Journal:  Hematol Oncol Clin North Am       Date:  2012-06       Impact factor: 3.722

Review 2.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

3.  Rationale for combining biotherapy in the treatment of advanced colon cancer.

Authors:  Deirdre J Cohen; Howard S Hochster
Journal:  Gastrointest Cancer Res       Date:  2008-05

4.  Systemic therapy for metastatic renal cell carcinoma: a review and update.

Authors:  Joshua E Logan; Edward N Rampersaud; Geoffrey A Sonn; Karim Chamie; Arie S Belldegrun; Allan J Pantuck; Dennis J Slamon; Fairooz F Kabbinavar
Journal:  Rev Urol       Date:  2012

5.  Update on anti-angiogenic therapy in non-small cell lung cancer: Are we making progress?

Authors:  Grzegorz Korpanty; Elizabeth Smyth; Desmond N Carney
Journal:  J Thorac Dis       Date:  2011-03       Impact factor: 2.895

6.  Autogrid-based clustering of kinases: selection of representative conformations for docking purposes.

Authors:  Giovanni Marzaro; Alessandro Ferrarese; Adriana Chilin
Journal:  Mol Divers       Date:  2014-05-29       Impact factor: 2.943

Review 7.  Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.

Authors:  Nikolett M Biel; Dietmar W Siemann
Journal:  Cancer Lett       Date:  2014-10-12       Impact factor: 8.679

8.  AT-rich sequence binding protein 1: Contribution to tumor progression and metastasis of human ovarian carcinoma.

Authors:  Jiangdong Xiang; Lina Zhou; Shuangdi Li; Xiaowei Xi; Jiarong Zhang; Yanqiu Wang; Yixia Yang; Xuelian Liu; Xiaoping Wan
Journal:  Oncol Lett       Date:  2012-01-16       Impact factor: 2.967

Review 9.  Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.

Authors:  Nikhil G Thaker; Ian F Pollack
Journal:  Expert Rev Neurother       Date:  2009-12       Impact factor: 4.618

10.  SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression.

Authors:  Lieven Huang; Lea Olive Tchouate Gainkam; Vicky Caveliers; Chris Vanhove; Marleen Keyaerts; Patrick De Baetselier; Axel Bossuyt; Hilde Revets; Tony Lahoutte
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.